Correlation Between Kiora Pharmaceuticals and Enveric Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Enveric Biosciences, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Enveric Biosciences.

Diversification Opportunities for Kiora Pharmaceuticals and Enveric Biosciences

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kiora and Enveric is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Enveric Biosciences go up and down completely randomly.

Pair Corralation between Kiora Pharmaceuticals and Enveric Biosciences

Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 1.0 times more return on investment than Enveric Biosciences. However, Kiora Pharmaceuticals is 1.0 times more volatile than Enveric Biosciences. It trades about -0.07 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.46 per unit of risk. If you would invest  364.00  in Kiora Pharmaceuticals on August 26, 2024 and sell it today you would lose (27.00) from holding Kiora Pharmaceuticals or give up 7.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kiora Pharmaceuticals  vs.  Enveric Biosciences

 Performance 
       Timeline  
Kiora Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Kiora Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Enveric Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Kiora Pharmaceuticals and Enveric Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiora Pharmaceuticals and Enveric Biosciences

The main advantage of trading using opposite Kiora Pharmaceuticals and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.
The idea behind Kiora Pharmaceuticals and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets